Market Research Report
Women's Health Market Size, Share & Trends Analysis By Application (Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, PCOS), By Region, And Segment Forecasts, 2019 - 2026
|Published by||Grand View Research, Inc.||Product code||581981|
|Published||Content info||130 Pages
Delivery time: 2-3 business days
|Women's Health Market Size, Share & Trends Analysis By Application (Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, PCOS), By Region, And Segment Forecasts, 2019 - 2026|
|Published: August 12, 2019||Content info: 130 Pages||
The global women's health market size is expected to reach USD 54.6 billion by 2026, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.2% over the forecast period. Government and various private organizations are focused on women health across the globe, which is likely to drive the market in the coming years. Coverage provided to women is one of the key factors expected to drive the market in developed countries.
In the U.S., coverage plans provide preventive services for women without any copayment charges. This includes anemia screening on a routine basis, folic acid supplements for women who may become pregnant, hepatitis B screening, breast cancer screening, contraception, and many others. Healthy People 2020 was established by the Department of Health and Human Services to improve the health of all Americans in 10 years.
Initiatives by countries from the Asia Pacific region, such as India, China, Japan, Australia, and Singapore, are likely to boost the market over the forecast period. For instance, in September 2016, Ministry of Health, Australia, announced funding of AUD 5.6 million (around USD 3.8 million) until 2019 to Jean Hailes, a women's health organization to help expand its education and outreach.
With aging and increasing incidence of obesity, the prevalence of OA is anticipated to grow. According to the United Nations, about 10% to 15% of all adults aged over 60 have some degree of OA, and the condition is more prevalent in women. According to the CDC, in 2013, back problems were more common in women (30.2%). According to the International Osteoporosis Foundation (IOF), the worldwide prevalence of osteoporosis among women was over 200.0 million in 1990, which is anticipated to reach 680.0 million in 2050.
Some of the key players in the market are: Bayer AG; Allergan; Merck & Co., Inc.; Teva Pharmaceuticals; Pfizer; Agile Therapeutics; Amgen, Inc.; AstraZeneca, Bristol-Myers Squibb, Ferring B.V.